Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users

Podobne zapisy

• Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
  od: Cadegiani, Flavio A., i wsp.
  Wydane: (2020)
• Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
  od: Cadegiani, Flavio A, i wsp.
  Wydane: (2021)
• Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
  od: Goren, Andy, i wsp.
  Wydane: (2021)
• Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)
  od: Cadegiani, Flavio A., i wsp.
  Wydane: (2020)
• Are night shift workers at an increased risk for COVID-19?
  od: Lim, Rachel K., i wsp.
  Wydane: (2020)